Claritev Tops Q2 Estimates and Lifts Full-Year Outlook on Surging Bookings
CTEV has more than doubled off its 52-week low of $11.5.
Summary
Claritev posted Q2 2026 revenue of $257.5M (up 6.6% YoY) and adjusted EBITDA of $155.8M, beating expectations. The company raised full-year guidance and highlighted $70M+ in H1 bookings, signaling accelerating growth.
Key Events · Earnings and Guidance · CTEV
-
Q2 Revenue and EBITDA Beat
Revenue of $257.5M grew 6.6% YoY, beating consensus by 5.2%. Adjusted EBITDA of $155.8M (60.5% margin) beat by 3.5%, though margin compressed from 63.8% a year ago.
-
Full-Year Guidance Raised
Revenue guidance lifted to $1B-$1.02B (from $985M-$1B), Adjusted EBITDA to $610M-$620M (from $605M-$615M), and Free Cash Flow to $5M-$15M (from $0M-$10M).
-
Bookings Momentum Accelerating
Over $70M in bookings in H1 2026, on pace for $100M full-year target — a 50% increase over 2025. Strength was broad-based across solutions and verticals, with notable TPA wins.
-
Cash Flow and Balance Sheet
Operating cash flow surged to $92.7M in Q2 (vs. $61.2M a year ago). Unrestricted cash remains low at $14.4M, with $70M drawn on the revolver, but free cash flow turned positive at $54.6M for the quarter.
Analysis · CTEV · Trade & Services
A strong Q2 beat across the board underscores the turnaround: revenue of $257.5M exceeded consensus by 5.2%, and adjusted EBITDA of $155.8M came in 3.5% ahead of expectations, prompting a raise in full-year revenue and EBITDA guidance. Bookings momentum is accelerating—over $70M in the first half puts the company on track for $100M in 2026, a 50% jump over 2025. While the balance sheet remains tight with only $14.4M in unrestricted cash, operating cash flow improved sharply to $92.7M in the quarter. This print reinforces the turnaround narrative and validates the Vision 2030 transformation program, coming just two months after the DOJ closed its antitrust probe without action.
At the time of this filing, CTEV was trading at $26.84 on NYSE in the Trade & Services sector, with a market capitalization of approximately $457.6M. The 52-week trading range was $11.50 to $74.07. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.